Is a complete CGEN research report available?

No complete published report is available for Compugen Ltd. (CGEN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Compugen Ltd. (CGEN)

NASDAQ: CGEN · USD

$1.99

+0.02 (+1.0%)· Recorded snapshot

Market cap	188.5M
Revenue (ttm)	74M
Net income (ttm)	35.2M
EPS (ttm)	$0.37
Shares out	94.7M
P/E (trailing)	5.3x
Volume	146,168
Beta	2.79

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 74M
Net income (ttm): 35.2M
EPS (ttm): $0.37
P/E (trailing): 5.3x
Market cap: 188.5M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

Metric	Value
Amount currency	USD
CIK code	0001119774
Company name	Compugen Ltd.
Country	Israel
Country code	US
CUSIP number	M25722105
Earnings date	2026-11-09
Earnings time	bmo
Employees	75
Employees change	1
Employees growth	1.35%
Enterprise value	$66.2M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1993
Industry	Biotechnology
IPO date	2000-08-11
Is primary listing	Yes
Is SPAC	No
ISIN number	IL0010852080
Last 10-K release date	2026-03-02
Last earnings date	2026-08-03
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$188.5M
Market cap category	Micro-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$1.99
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	CGEN
Website	https://cgen.com

Metric

Value

Amount currency

USD

CIK code

0001119774

Company name

Compugen Ltd.

Country

Israel

Country code

CUSIP number

M25722105

Earnings date

2026-11-09

Earnings time

bmo

Employees

Employees change

Employees growth

1.35%

Enterprise value

$66.2M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

1993

Industry

Biotechnology

IPO date

2000-08-11

Is primary listing

Yes

Is SPAC

ISIN number

IL0010852080

Last 10-K release date

2026-03-02

Last earnings date

2026-08-03

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$188.5M

Market cap category

Micro-Cap

Next earnings date

2026-11-09

Options

Yes

Price

$1.99

Price currency

USD

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-28

Symbol

CGEN

Website

https://cgen.com

Metric	Value
Adjusted P/E ratio	5.24x
Earnings yield	18.76%
EV/Earnings	1.87x
EV/EBIT	2.17x
EV/EBITDA	2.14x
EV/FCF	2.34x
EV/Sales	0.89x
FCF / EV yield	42.79%
FCF yield	14.96%
Forward EV/Sales	12.21x
Forward P/S	34.93x
Graham number	2.80507
Graham upside	41.31%
P/(FCF - SBC) ratio	7.05x
P/(OCF - SBC) ratio	7.02x
P/B ratio	2.1x
P/E ratio	5.33x
P/FCF ratio	6.68x
P/OCF ratio	6.66x
P/S ratio	2.54x
Price / tangible book value	2.12x
Price/EBITDA ratio	6.13x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Adjusted P/E ratio

5.24x

Earnings yield

18.76%

EV/Earnings

1.87x

EV/EBIT

2.17x

EV/EBITDA

2.14x

EV/FCF

2.34x

EV/Sales

0.89x

FCF / EV yield

42.79%

FCF yield

14.96%

Forward EV/Sales

12.21x

Forward P/S

34.93x

Graham number

2.80507

Graham upside

41.31%

P/(FCF - SBC) ratio

7.05x

P/(OCF - SBC) ratio

7.02x

P/B ratio

2.1x

P/E ratio

5.33x

P/FCF ratio

6.68x

P/OCF ratio

6.66x

P/S ratio

2.54x

Price / tangible book value

2.12x

Price/EBITDA ratio

6.13x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
EBIT margin	40.94%
EBITDA margin	41.45%
Effective tax rate	0.15%
FCF margin	38.02%
Gross margin	86.89%
Operating margin	40.94%
Pretax margin	47.63%
Profit margin	47.55%
Profit per employee	$469,213
Profitable years	1
Revenue per employee	$986,680
ROA	15.46%
ROA (5Y)	-7.35%
ROCE	26.18%
ROE	50.64%
ROE (5Y)	-14.35%
ROIC	26.12%
SBC / revenue	1.98%
Tax / revenue	0.07%

Metric

Value

EBIT margin

40.94%

EBITDA margin

41.45%

Effective tax rate

0.15%

FCF margin

38.02%

Gross margin

86.89%

Operating margin

40.94%

Pretax margin

47.63%

Profit margin

47.55%

Profit per employee

$469,213

Profitable years

Revenue per employee

$986,680

ROA

15.46%

ROA (5Y)

-7.35%

ROCE

26.18%

ROE

50.64%

ROE (5Y)

-14.35%

ROIC

26.12%

SBC / revenue

1.98%

Tax / revenue

0.07%

Metric	Value
EPS growth years	4
Gross profit growth	365.82%
Gross profit growth 3Y	114.39%
Gross profit growth 5Y	101.41%
Net income growth quarters	1
Net income growth years	4
Revenue growth	234.18%
Revenue growth (Q)	107%
Revenue growth (QoQ)	19.58%
Revenue growth 10Y	23.28%
Revenue growth 3Y	114.48%
Revenue growth 5Y	105.89%
Revenue growth quarters	1
Revenue growth years	1

Metric

Value

EPS growth years

Gross profit growth

365.82%

Gross profit growth 3Y

114.39%

Gross profit growth 5Y

101.41%

Net income growth quarters

Net income growth years

Revenue growth

234.18%

Revenue growth (Q)

107%

Revenue growth (QoQ)

19.58%

Revenue growth 10Y

23.28%

Revenue growth 3Y

114.48%

Revenue growth 5Y

105.89%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-116,000
Depreciation and amortization	$380,000
EBIT	$30.3M
EBITDA	$30.7M
EPS	$0.37
FCF per share	$0.30
Financing cash flow	$1.8M
Free cash flow	$28.1M
Free cash flow minus SBC	$26.7M
Gross profit	$64.3M
Income taxes	$52,000
Investing cash flow	$-27M
Net cash flow	$3.8M
Net income	$35.2M
Operating cash flow minus SBC	$26.8M
Operating income	$30.3M
Revenue	$74M
Stock-based compensation	$1.5M

Metric

Value

Capital expenditures

$-116,000

Depreciation and amortization

$380,000

EBIT

$30.3M

EBITDA

$30.7M

EPS

$0.37

FCF per share

$0.30

Financing cash flow

$1.8M

Free cash flow

$28.1M

Free cash flow minus SBC

$26.7M

Gross profit

$64.3M

Income taxes

$52,000

Investing cash flow

$-27M

Net cash flow

$3.8M

Net income

$35.2M

Operating cash flow minus SBC

$26.8M

Operating income

$30.3M

Revenue

$74M

Stock-based compensation

$1.5M

Metric	Value
Altman Z-Score	-0.4
Book value per share	$0.94
Debt / EBITDA	0.1
Debt / equity	0.03
Debt / FCF	0.11
Long-term assets	$9M
Long-term liabilities	$27M
Net cash (debt)	$122.3M
Net cash / market cap	65.03%
Net cash growth	34.51%
Net debt / EBITDA	-3.99
Net debt / equity	-1.38
Net debt / FCF	-4.35
Piotroski F-Score	6
Property, plant and equipment	$3.1M
Shareholders' equity	$88.7M
Tangible book value	$88.7M
Tangible book value per share	$0.94
Total assets	$138.4M
Total cash	$125.3M
Total debt	$3M
Total liabilities	$49.6M
WACC	19.28%

Metric

Value

Altman Z-Score

-0.4

Book value per share

$0.94

Debt / EBITDA

0.1

Debt / equity

0.03

Debt / FCF

0.11

Long-term assets

$9M

Long-term liabilities

$27M

Net cash (debt)

$122.3M

Net cash / market cap

65.03%

Net cash growth

34.51%

Net debt / EBITDA

-3.99

Net debt / equity

-1.38

Net debt / FCF

-4.35

Piotroski F-Score

Property, plant and equipment

$3.1M

Shareholders' equity

$88.7M

Tangible book value

$88.7M

Tangible book value per share

$0.94

Total assets

$138.4M

Total cash

$125.3M

Total debt

$3M

Total liabilities

$49.6M

WACC

19.28%

Metric	Value
Asset turnover	0.6
Current assets	$129.4M
Current liabilities	$22.6M
Current ratio	5.72
Net working capital	$-17.9M
Quick ratio	5.72
Working capital	$106.8M
Working capital turnover	0.81

Metric

Value

Asset turnover

0.6

Current assets

$129.4M

Current liabilities

$22.6M

Current ratio

5.72

Net working capital

$-17.9M

Quick ratio

5.72

Working capital

$106.8M

Working capital turnover

0.81

Metric	Value
Buyback yield / dilution	-3.76%
Dividend yield	0%
Shareholder yield	-3.76%

Metric

Value

Buyback yield / dilution

-3.76%

Dividend yield

Shareholder yield

-3.76%

Metric	Value
10Y price change	-64.64%
10Y return CAGR	-9.88%
10Y total return	-64.64%
150-day SMA	$2.41
15Y price change	-54.79%
15Y return CAGR	-5.16%
15Y total return	-54.79%
1D price change	1.02%
1M price change	-16.81%
1M total return	-16.81%
1W price change	-7.48%
1W total return	-7.48%
1Y price change	15.79%
1Y return CAGR	15.8%
1Y total return	15.79%
20-day SMA	$2.08
200-day SMA	$2.30
20Y price change	-30.77%
20Y return CAGR	-1.82%
20Y total return	-30.77%
3M price change	-16.81%
3M total return	-16.81%
3Y price change	190.32%
3Y return CAGR	42.65%
3Y total return	190.32%
50-day SMA	$2.34
50-day SMA vs 200-day SMA	50over200
52-week high	$3.24
52-week high date	2026-04-24
52-week low	$1.43
52-week low date	2025-12-30
5Y price change	-67.65%
5Y return CAGR	-20.21%
5Y total return	-67.65%
6M price change	-32.19%
6M total return	-32.19%
All-time high	$19.90
All-time high date	2020-08-26
All-time low	$0.34
All-time low date	2008-11-24
Average true range (ATR)	$0.10
Average volume	234.2K
Beta (1Y)	1.7
Beta (2Y)	1.43
Beta (5Y)	2.79
Change from 52-week high	-38.49%
Change from 52-week low	39.16%
Change from all-time high	-90.05%
Change from all-time low	482.35%
Change from open	1.02%
Day's gap	0%
Dollar volume	$290,874
High price	$2.01
Low price	$1.97
Monthly RSI	49.03
Open price	$1.97
Position in 52-week range	50%
Premarket change	0%
Premarket close	$1.97
Premarket price	$1.97
Previous close	$1.97
Price vs 150-day SMA	-17.71%
Price vs 20-day SMA	-4.85%
Price vs 200-day SMA	-13.76%
Price vs 50-day SMA	-15.53%
Relative volume	0.62
RSI	40.32
Sharpe ratio	0.48
Sharpe ratio (3Y)	0.65
Sharpe ratio (5Y)	0.15
Sortino ratio	0.88
Sortino ratio (3Y)	1.91
Sortino ratio (5Y)	0.4
Volume	146.2K
Weekly RSI	40.33
YTD price change	29.41%
YTD total return	29.41%

Metric

Value

10Y price change

-64.64%

10Y return CAGR

-9.88%

10Y total return

-64.64%

150-day SMA

$2.41

15Y price change

-54.79%

15Y return CAGR

-5.16%

15Y total return

-54.79%

1D price change

1.02%

1M price change

-16.81%

1M total return

-16.81%

1W price change

-7.48%

1W total return

-7.48%

1Y price change

15.79%

1Y return CAGR

15.8%

1Y total return

15.79%

20-day SMA

$2.08

200-day SMA

$2.30

20Y price change

-30.77%

20Y return CAGR

-1.82%

20Y total return

-30.77%

3M price change

-16.81%

3M total return

-16.81%

3Y price change

190.32%

3Y return CAGR

42.65%

3Y total return

190.32%

50-day SMA

$2.34

50-day SMA vs 200-day SMA

50over200

52-week high

$3.24

52-week high date

2026-04-24

52-week low

$1.43

52-week low date

2025-12-30

5Y price change

-67.65%

5Y return CAGR

-20.21%

5Y total return

-67.65%

6M price change

-32.19%

6M total return

-32.19%

All-time high

$19.90

All-time high date

2020-08-26

All-time low

$0.34

All-time low date

2008-11-24

Average true range (ATR)

$0.10

Average volume

234.2K

Beta (1Y)

1.7

Beta (2Y)

1.43

Beta (5Y)

2.79

Change from 52-week high

-38.49%

Change from 52-week low

39.16%

Change from all-time high

-90.05%

Change from all-time low

482.35%

Change from open

1.02%

Day's gap

Dollar volume

$290,874

High price

$2.01

Low price

$1.97

Monthly RSI

49.03

Open price

$1.97

Position in 52-week range

50%

Premarket change

Premarket close

$1.97

Premarket price

$1.97

Previous close

$1.97

Price vs 150-day SMA

-17.71%

Price vs 20-day SMA

-4.85%

Price vs 200-day SMA

-13.76%

Price vs 50-day SMA

-15.53%

Relative volume

0.62

RSI

40.32

Sharpe ratio

0.48

Sharpe ratio (3Y)

0.65

Sharpe ratio (5Y)

0.15

Sortino ratio

0.88

Sortino ratio (3Y)

1.91

Sortino ratio (5Y)

0.4

Volume

146.2K

Weekly RSI

40.33

YTD price change

29.41%

YTD total return

29.41%

Metric	Value
Float	94.5M
Float percentage	99.78%
Shares change (QoQ)	0.09%
Shares change (YoY)	3.76%
Shares held by insiders	0.22%
Shares held by institutions	16.33%
Shares outstanding	94.7M
Short % of shares	2.49%
Short ratio	13.7 days

Metric

Value

Float

94.5M

Float percentage

99.78%

Shares change (QoQ)

0.09%

Shares change (YoY)

3.76%

Shares held by insiders

0.22%

Shares held by institutions

16.33%

Shares outstanding

94.7M

Short % of shares

2.49%

Short ratio

13.7 days

Compugen Ltd. (CGEN)

Price

Financial snapshot

Fair-value bridge

Latest news · CGEN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CGEN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CGEN

Frequently asked questions